Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 11, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change reported is the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on July 10, 2007. Each individual acquired 10 shares through the personal contribution element and 10 shares through the company matching element of the ShareReward Plan. The transaction price was GBP 12.80 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific share transactions mentioned above.
Investor Verification Points
- Verify the share price of GBP 12.80 per Ordinary Share on July 10, 2007.
- Confirm the terms of the ShareReward Plan entered into on October 5, 2001, specifically regarding the matching element.
- Review the total shareholding positions of Mr. Heslop, Mr. Bondy, Mr. Learmouth, and Mr. Witty following these acquisitions.